How is your January starting?

u/Itsyournamebackwards · Reddit — r/smallstreetbets · January 21, 2026 at 22:53 · ⬆ 3 pts · 💬 1 comments  | View on Reddit ↗
AI Summary

Original Reddit post

Author is buying IBRX because Anktiva could become a platform drug like GLP-1 with cancer and COVID applications.

IBRX — LONG Author started buying IBRX around $2 and averaged up after Anktiva's lung cancer approval in Saudi. Anktiva is viewed as a platform drug with potential analogous to GLP-1 success for cancer and COVID treatment, and could challenge Merck.

This will be a platform drug that will make Merck piss there pants. Think GLP-1 success for cancer treatment, COVID treatment, etc.

Score 3
Comments 1
▶ Full Post Text
Ideas
u/Itsyournamebackwards Reddit r/smallstreetbets
IBRX platform drug with Anktiva approval catalyst.
Author started buying IBRX around $2 and averaged up after Anktiva's lung cancer approval in Saudi. Anktiva is viewed as a platform drug with potential analogous to GLP-1 success for cancer and COVID treatment, and could challenge Merck.
IBRX HIGH
More from Reddit — r/smallstreetbets
What’s everyone’s YTD so far?
Jan 21, 21:55
weeklyish update, made it out alive somehow
Jan 21, 21:46
$100 to $1000
Jan 21, 21:02
Palladyne is part of the supply chain for Anduril's Fury
Jan 21, 20:51
Bad day smh will get em tomorrow
Jan 21, 20:41

This Reddit post, published January 21, 2026, features u/Itsyournamebackwards discussing IBRX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/Itsyournamebackwards  · Tickers: IBRX